- Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion therapy
Hiroya Iida et al, 2018, Molecular and Clinical Oncology CrossRef - Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States
Veena Shankaran et al, 2018, American Journal of Clinical Oncology CrossRef - Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential
Linda M. Pak et al, 2018, Journal of Surgical Oncology CrossRef - Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors
Eva Lieto et al, 2018, Surgical Innovation CrossRef - Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence
Diamantis I. Tsilimigras et al, 2018, Surgical Oncology CrossRef - Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021
Masakazu Yamamoto et al, 2021, Journal of Hepato-Biliary-Pancreatic Sciences CrossRef - Combined Liver and Colon Resection of Synchronous Colorectal Liver Metastases at a Quaternary Center
Kevin Choong et al, 2023, Journal of Surgical Research CrossRef - Cost-effectiveness of cetuximab for colorectal cancer
Taehwan Park et al, 2016, Expert Review of Pharmacoeconomics & Outcomes Research CrossRef - Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review
Kaitlyn K.H. Goey et al, 2016, European Journal of Cancer CrossRef - Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump
Benjamin S. Strnad et al, 2021, American Journal of Roentgenology CrossRef - Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study
M. Takatsuki et al, 2016, European Journal of Surgical Oncology (EJSO) CrossRef - S-1/irinotecan/oxaliplatin chemotherapy achieved a pathological complete remission in advanced pancreatic carcinoma
Ru Chen et al, 2024, Clinical Journal of Gastroenterology CrossRef